Skip to headlines

AI

How AI helps scientists design the next generation of medicines

MIT Technology Review AIThursday, July 23, 2026 at 12:00 PM

RedScroll Brief

How AI helps scientists design the next generation of medicines
Image via MIT Technology Review AI

Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment.

RedScroll Signal

Impact
High
Category
Ai
Market relevance
Moderate
Why it matters
AI developments move capital, regulation, and competitive advantage across the tech stack. Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment. Secondary effects may show up in markets and supply chains linked to AI and Helps.
Read original source → MIT TECHNOLOGY REVIEW AIEdition 2026-07-23

Desk copy

RedScroll Briefing

Extractive editorial brief — not a reprint of the original

What happened

Designing and developing a new medicine is an expensive, failure-prone scientific challenge. A new drug can take many years to develop, at the cost of a significant investment.

Why it matters

AI developments move capital, regulation, and competitive advantage across the tech stack.

Background

MIT Technology Review AI reported on this under ai. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.

Timeline

  1. MIT Technology Review AI published: How AI helps scientists design the next generation of medicines

  2. Story is in today’s RedScroll edition. Follow the original source for updates.

Economic impact

Secondary effects may show up in markets and supply chains linked to AI and Helps.

More on

Related stories

Source

MIT Technology Review AI

Original reporting by MIT Technology Review AI. RedScroll provides an extractive briefing only.